Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
SEC Accession No. 0000936392-97-001543
Filing Date
1997-11-17
Accepted
1997-11-17 00:00:00
Documents
3
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #1 TO SCHEDULE 13E3 SC 13E3/A 85076
2 EXHIBIT 99.2 EX-99.2 32325
3 EXHIBIT 99.3 EX-99.3 11589
  Complete submission text file 0000936392-97-001543.txt   131160
Mailing Address 9393 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DR STE 100 SAN DIEGO CA 92121 6195353900
LIGAND PHARMACEUTICALS INC (Filed by) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 DUPONT DR IRVINE CA 92715
Business Address 9393 TOWNE CENTER DR SAN DIEGO CA 92121 6195353900
ALLERGAN LIGAND RETINOID THERAPEUTICS INC (Subject) CIK: 0000934592 (see all company filings)

EIN.: 330642614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13E3/A | Act: 34 | File No.: 005-45829 | Film No.: 97722814
SIC: 2834 Pharmaceutical Preparations